Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.639 USD | +5.43% | +2.90% | -52.67% |
Financials (USD)
Sales 2024 * | 3K | Sales 2025 * | 2.5M | Capitalization | 22.93M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -77M | EV / Sales 2024 * | 7,643 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 9.16 x |
P/E ratio 2024 * |
-0.42
x | P/E ratio 2025 * |
-0.48
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Biora Therapeutics, Inc.
1 day | +5.43% | ||
1 week | +2.90% | ||
Current month | -41.91% | ||
1 month | -47.62% | ||
3 months | -34.19% | ||
6 months | -73.81% | ||
Current year | -52.67% |
Managers | Title | Age | Since |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 19-04-30 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 14-05-31 | |
Jeffrey Alter
CHM | Chairman | 61 | 18-12-31 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.6061 | -1.45% | 160,218 |
24-04-19 | 0.615 | +2.59% | 105,736 |
24-04-18 | 0.5995 | -6.63% | 519,543 |
24-04-17 | 0.6421 | +3.40% | 317,789 |
24-04-16 | 0.621 | +0.16% | 244,168 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.67% | 21.75M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- BIOR Stock